Clinical pharmacokinetic studies consistently show that oral administration of GlyNAC leads to a rapid, dose-dependent increase in circulating plasma levels of both amino acids, typically reaching peak concentrations within just one to two hours of ingestion
Therefore, high glucose levels can make patients with T2DM more susceptible to COVID-19, as hyperglycemia can affect the production of enzymes that help the SARS-CoV-2 infect and multiply in the body (Michaels et al., 2024)
Dr Jastreboff notes that mild to moderate gastrointestinal side effects are possible
The peptide does not cause rapid weight loss, nor should it
Warning: If you are pregnant, nursing, or taking any medications, consult a healthcare professional before use